Renaissance Capital logo

XFOR News

US IPO Weekly Recap: 9 IPOs in final feast before Thanksgiving

ASNS

Nine companies came public this week raising a combined $1.1 billion, plus one blank check company. The week's three largest expected IPOs postponed. All but two companies priced below the target midpoint. Enterprise tech darlings SailPoint and...read more

Pneumonia biotech Arsanis prices IPO at $10

X4 Pharmaceuticals (Arsanis) logo

Arsanis, which is developing antibodies designed to prevent serious infectious diseases, raised $40 million by offering 4 million shares at $10, below the initial $15 to $17 range. Arsanis plans to list on the Nasdaq under the symbol ASNS. Citi, Cowen &...read more

Pneumonia biotech Arsanis decreases proposed IPO deal size

X4 Pharmaceuticals (Arsanis) logo

Arsanis, which is developing antibodies designed to prevent serious infectious diseases, lowered the proposed deal size for its upcoming IPO on Wednesday. The Waltham, MA-based company now plans to raise $40 million by offering 4 million shares at a price...read more

US IPO Week Ahead: Back-to-back record activity with 12 IPOs set to price

WSPT

Following the busiest week of 2017, the week ahead will be another record breaker with 12 IPOs scheduled to raise a combined $2.1 billion. The week will be led by automated email platform SendGrid and cybersecurity...read more